Results 71 to 80 of about 11,691 (245)

Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA

Toxins
The therapeutic efficacy remaining from prior treatments with botulinum toxins (BoNTs) when cervical dystonia (CD) patients prefer to be re-treated has not been well characterized. Here, we assessed the residual therapeutic efficacy of BoNT injections at
Aaron Ellenbogen, Robert A. Hauser, Atul T. Patel, Peter McAllister, Todd M. Gross, Rashid Kazerooni, Conor J. Gallagher, David A. Hollander   +7 more
doaj   +1 more source

Delayed emergence from anaesthesia and bilateral mydriasis following bilateral pallidotomy

Indian Journal of Anaesthesia, 2018
Pallidotomy is a surgical procedure done widely for Parkinson's disease and various dystonias refractory to medical treatment. The technique involves radiofrequency (RF) thermal coagulation of globus pallidus internus, either unilaterally or bilaterally.
Ankur Khandelwal, Mihir Prakash Pandia, Ritesh Lamsal   +2 more
doaj   +1 more source

Neurodevelopmental disorder with dystonia due to SOX6 mutations

Molecular Genetics & Genomic Medicine, 2022
Background Mutations in SOX6 have recently been recognized as a new molecular cause of neurodevelopmental disorders characterized by intellectual disability, behavioral changes, and nonspecific facial and digital skeletal abnormalities. To date, T.
Susanne A. Schneider, Christine Mueller, Saskia Biskup, Urban M. Fietzek, Andreas Sebastian Schroeder   +4 more
doaj   +1 more source

Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study

BackgroundTremor disorders remain as clinical diagnoses and the rate of misdiagnosis between the commonest non-parkinsonian tremors is relatively high.ObjectivesTo compare the clinical features of Essential Tremor without other features (pure ET), ET ...
Colombatto F., Pacchetti C., Altavista M. C., Franco G., Raglione L. M., Aramini S., di Biase L., Malaguti M. C., Giordano C., Modugno N., Di Giacopo R., Di Fonzo A., Ceravolo R., Bacchin R., Bertino S., Esposito M., Barone P., Gigante A. F., De Micco R., De Rosa A., Angelini L., Valentino F., Erro R., Nicoletti A., Sorrentino C., Moschella V., Di Maggio G., Marchese R., Terranova C., Bianchi M., Del Prete E., Magistrelli L., Spagnolo F., Russo M., Castagna A., Trinchillo A., Paparella G., Bologna M., Mostile G., Volpe G., Olivola E., Savorgnan G., Pilotto A., Padovani A., Manzo N., Rizzo V., Tessitore A., Misceo S., Benzi Markushi T., Di Biasio F., Lazzeri G., Zoccolella S., Contaldi E., Giglio A., Dallocchio C.   +54 more
core   +2 more sources

Reply to: Deprescribing after DBS in Dystonia: Promise, Pitfalls, and a Path Forward

Movement Disorders Clinical Practice, EarlyView.
Marcela A. Montiel, Alfonso Fasano
wiley   +1 more source

Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information

Toxins
The first-line management of cervical dystonia (CD) symptoms is intramuscular injection of botulinum toxin type A (BoNTA). However, a comparison of safety among BoNTAs is difficult because, per regulatory authorities, units of BoNTA activity are not ...
Khashayar Dashtipour, Han S. Lee, Aaron Ellenbogen, Rashid Kazerooni, Todd M. Gross, David A. Hollander, Conor J. Gallagher   +6 more
doaj   +1 more source

Dystonic opisthotonus: A "red flag" for neurodegeneration with brain iron accumulation syndromes? [PDF]

, 2013
Back arching was reported in one of the very first patients with neurodegeneration with brain iron accumulation syndrome (NBIAs) published in 1936. However, recent reports have mainly focused on the genetic and imaging aspects of these disorders, and the
Lu, C-S, Houlden, H, Stamelou, M, Bhatia, KP, Lai, SC, Aggarwal, A, Batla, A, Schneider, SA, Bhatt, M, Yeh, T-H   +9 more
core  

Dystonia in atypical parkinsonian disorders

, 2019
Dystonia is common in the classic atypical parkinsonian disorders such as multiple system atrophy, progressive supranuclear palsy and corticobasal degeneration, and to a lesser extent in dementia with Lewy bodies.
Colosimo C., Marsili L., Espay A. J., Kojovic M., Bologna M., Berardelli A.   +5 more
core   +1 more source

Pilomotor Seizures in a Patient With LGI1 Encephalitis

Frontiers in Neurology, 2020
Limbic encephalitis (LE) with antibodies against leucine-rich glioma inactivated protein 1 (LGI1) is an autoimmune disease with variable clinical features, including seizures, cognitive disorders, psychiatric disturbances, and hyponatremia.
Jinxia Yang, Qiying Sun, Guang Yang
doaj   +1 more source

Severity‐Based and Family‐Centered Approaches to Deep Brain Stimulation in GNAO1‐Related Disorders

Movement Disorders Clinical Practice, EarlyView.
Jana Domínguez‐Carral, Juan Darío Ortigoza‐Escobar   +1 more
wiley   +1 more source